Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease

M. Savarese, A. Torella, O. Musumeci, C. Angelini, G. Astrea, L. Bello, C. Bruno, G.P. Comi, G. Di Fruscio, G. Piluso, G. Di Iorio, M. Ergoli, G. Esposito, M. Fanin, O. Farina, C. Fiorillo, A. Garofalo, T. Giugliano, F. Magri, C. MinettiM. Moggio, L. Passamano, E. Pegoraro, E. Picillo, S. Sampaolo, F.M. Santorelli, C. Semplicini, B. Udd, A. Toscano, L. Politano, V. Nigro

    Research output: Contribution to journalArticleScientificpeer-review

    20 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)586-591
    JournalNEUROMUSCULAR DISORDERS
    Volume28
    Issue number7
    DOIs
    Publication statusPublished - 2018
    Publication typeA1 Journal article-refereed

    Keywords

    • GAA
    • Gene panels
    • HyperCKemia
    • LGMD
    • Late onset Pompe disease (LOPD)
    • Metabolic myopathies

    Publication forum classification

    • Publication forum level 1

    Cite this